Hepatitis C Therapy - Annual 25-30% Growth in Use of Health Care Resources among HCV Patients for Hospitalizations, Charges, Hospita

Daily Mail - Rising numbers of people suffering severe liver disease caused by

Annual 25-30% Growth in Use of Health Care Resources among HCV Patients for Hospitalizations, Charges, Hospita
HIV and Hepatitis.com - As individuals with

GlobeImmune Relocates Corporate Headquarters
Pharma Live - LOUISVILLE, Colo., December 15, 2005 /PRNewswire/ -- GlobeImmune, Inc. today announced the relocation of its corporate headquarters to Louisville, Colorado. 1b trial for its second product, GI-5005, a Tarmogen for the treatment of chronic